HHS Cancels Autism Meeting, Epilepsy & Suicide Link, Talkspace Deal & More
Fine morning. A quick note for those following the evolving landscape of digital health: the legal dust has settled in the dispute between Hims & Hers and Novo Nordisk, but the broader questions about access, affordability, and the role of telehealth companies in prescribing medications remain. And, on a lighter note, a Boston-area observation: McDonald’s coffee continues to hold its own against the local favorites.
Autism Advisory Committee: A Pause Amidst Division
The federal advisory committee dedicated to autism research and policy – the Interagency Autism Coordinating Committee (IACC) – has postponed its upcoming meeting, originally scheduled for later this month. This cancellation follows the recent formation of an independent committee created in response to concerns about the composition of the federal group. Health Secretary Robert F. Kennedy Jr.’s appointments to the IACC, perceived by some as aligning with debunked theories linking vaccines to autism, prompted the creation of this alternative body. The news was initially reported over the weekend and confirmed by the Department of Health and Human Services (HHS) via a post on X (formerly Twitter) here.
The situation highlights ongoing tensions surrounding autism research and the influence of misinformation. STAT’s O. Rose Broderick provides further detail on the evolving situation here.
Suicidality and Epilepsy: A Complex Connection
New research published in JAMA Neurology suggests a significant link between suicidal ideation and attempts and a reduced response to antiseizure medications. The study, involving nearly 350 participants in the Human Epilepsy Project, found that experiencing suicidality – even without a concurrent diagnosis of a mood or anxiety disorder – substantially increased the risk of developing resistance to these medications.
Specifically, individuals with no psychiatric diagnoses had approximately a 16% chance of treatment resistance over six years. This risk increased to nearly 33% for those with anxiety disorders and jumped to 47% for those experiencing suicidality alone. Although the study’s sample size is relatively small and further research is needed, the authors propose that suicidality may serve as “a marker of more severe neuropathology.” This finding underscores the importance of comprehensive mental health screening and support for individuals with epilepsy.
Digital Health Deal: Universal Health Services Acquires Talkspace for $835 Million
In the evolving digital health sector, Universal Health Services (UHS) has agreed to acquire Talkspace, a virtual mental health company, for $835 million. This acquisition, announced yesterday, comes as the digital health landscape navigates post-pandemic shifts and varying levels of success. Talkspace has demonstrated consistent growth and stability, making it an attractive target for UHS. STAT’s Mario Aguilar provides a detailed analysis of the deal here. The acquisition signals continued consolidation within the virtual mental healthcare space.
Kidney Transplant Equity: Impact of Race-Neutral Algorithm
For decades, a clinical algorithm used to assess kidney function included an inflation for Black patients, a practice rooted in historical inequities and now widely recognized as harmful. The shift to a race-neutral equation, phased in beginning in 2022, aimed to address this disparity. A new study now quantifies the impact of this change. Researchers found that the policy adjustments were associated with a 5.3 increase in kidney transplants per 1,000 candidates among Black patients.
“Our study really shows, on a national scale, what the specific, quantifiable impacts of a remedy policy for the harms of the race-based equation were,” explained study author Rohan Khazanchi to STAT’s Anil Oza. Read more about the study’s findings and ongoing efforts to address systemic inequities in organ transplantation. This represents a significant step toward more equitable access to life-saving treatment, but advocates emphasize that further work is needed to dismantle remaining barriers.
The “Himsification” of Medicine: A Shift in Patient-Provider Dynamics
Physician Vishal Khetpal describes a concerning trend he terms the “Himsification” of medicine, exemplified by the recent legal battle between Hims & Hers and Novo Nordisk (which was settled yesterday). He argues that this phenomenon represents a fundamental shift in how patients approach healthcare, increasingly viewing themselves as consumers seeking specific products rather than individuals seeking diagnosis and treatment.
Khetpal suggests that this model encourages patients to arrive with a pre-determined diagnosis and a “shopping cart” of desired treatments, rather than presenting symptoms and engaging in a collaborative process with their physician. He contrasts this with the traditional model of medicine, where the physician plays a central role in diagnosis and treatment planning. His full essay, outlining the implications of this shift, is available on STAT here.
Access to Abortion Care: Barriers and Burdens
A qualitative study published yesterday in JAMA Network Open sheds light on the challenges faced by individuals seeking abortion care in states with restrictive laws. Researchers interviewed 33 patients at an Illinois clinic who had traveled from out of state to access abortion services. The study revealed significant financial and logistical burdens, as well as emotional distress.
Participants described fear of discussing abortion with others, difficulty finding reliable information online, and the need to travel long distances at considerable personal expense. One patient lamented being unable to afford to bring a loved one along for support, while another expressed feelings of isolation and despair. These findings underscore the profound impact of abortion restrictions on individuals’ access to essential healthcare.
What We’re Reading Elsewhere
- The surprising way breast cancer screenings could reveal heart disease, Washington Post
- The captivating derangement of the looksmaxxing movement, New Yorker
- Large drugmakers are developing fewer antibiotics, analysis finds, STAT
- The human egg sellers, NPR
Looking ahead: The implications of these findings will likely be discussed at upcoming meetings of the FDA’s advisory committees, as they consider potential updates to guidance on antiseizure medications and digital health technologies. Continued surveillance of transplant outcomes and ongoing efforts to address racial disparities in healthcare access will also be critical.